United Orthopedic Corporation (TPEX:4129)

Market Cap	8.32B
Revenue (ttm)	4.65B
Net Income (ttm)	455.96M
Shares Out	96.44M
EPS (ttm)	4.74
PE Ratio	18.21
Forward PE	14.70
Dividend	4.00 (4.76%)
Ex-Dividend Date	n/a

Volume	141,562
Average Volume	340,617
Open	87.50
Previous Close	86.30
Day's Range	86.20 - 88.20
52-Week Range	77.30 - 114.00
Beta	0.48
RSI	46.26
Earnings Date	Mar 28, 2025

About United Orthopedic

United Orthopedic Corporation engages in the research, development, manufacture, and sale of orthopedic implants and surgical instruments. The company offers artificial hip joints, partial hip joints, joints for large trochanteric fracture, Moore hip prosthesis, and customized artificial hip joints for individual tumor patients; artificial knee joint, such as artificial knee replacement joint, revision knee replacement system, restricted artificial knee joints, and customized artificial knee joints for individual tumor patients; and spine produ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1993
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 4129

Financial Performance

In 2024, United Orthopedic's revenue was 4.65 billion, an increase of 18.40% compared to the previous year's 3.93 billion. Earnings were 455.96 million, an increase of 20.11%.